World's Best Scientists 2026 revealed!
Xavier Anglaret

Xavier Anglaret

D-Index & Metrics

Immunology

D-Index
48
Citations
8720
World Ranking
4433
National Ranking
208

Overview

Xavier Anglaret is affiliated with the University of Bordeaux in France. Their research primarily focuses on medicine, with a concentration on infectious diseases, epidemiology, and virology, alongside interests in general health professions and nutrition and dietetics.

Their research topics cover a range of areas related to infectious diseases and public health, especially focused on HIV/AIDS and tuberculosis. These include:

  • HIV/AIDS drug development and treatment
  • HIV/AIDS research and interventions
  • HIV research and treatment
  • Tuberculosis research and epidemiology
  • Child nutrition and water access
  • Viral infections and outbreaks research
  • COVID-19 clinical research studies

Among their recent publications are the following papers, which provide insight into their research focus and contributions:

  • Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study (2021, The Lancet Global Health)
  • Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data (2020, The Lancet HIV)
  • Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults (2020, New England Journal of Medicine)
  • Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials (2020, CPT Pharmacometrics & Systems Pharmacology)
  • Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE) (2022, Clinical Microbiology and Infection)

Frequent co-authors include:

  • Anani Badjé
  • Delphine Gabillard
  • Serge Eholié
  • Christine Danel
  • Denis Malvy

Xavier Anglaret frequently publishes in:

  • SSRN Electronic Journal
  • Trials
  • The Lancet HIV
  • New England Journal of Medicine
  • International Journal of Infectious Diseases

Best Publications

  • A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

    Danel C;Moh R;Gabillard D

  • Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

    Stephen D Lawn;Anthony D Harries;Xavier Anglaret;Landon Myer

  • Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial

    Xavier Anglaret;Geneviève Chêne;Alain Attia;Siaka Toure

  • Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

    Daouda Sissoko;Cedric Laouenan;Elin Folkesson;Abdoul-Bing M’Lebing

  • Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

    Martin W. G. Brinkhof;François Dabis;Landon Myer;David R. Bangsberg

  • Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

    Francois Rouet;Didier K. Ekouevi;Marie-Laure Chaix;Marianne Burgard

  • Cost-effectiveness of HIV treatment in resource-poor settings - The case of Côte d'Ivoire

    Sue J. Goldie;Yazdan Yazdanpanah;Elena Losina;Milton C. Weinstein

  • CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.

    Christine Danel;Raoul Moh;Albert Minga;Amani Anzian

  • Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days.

    Boubacar Diallo;Daouda Sissoko;Nicholas J. Loman;Hadja Aïssatou Bah

  • Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.

    Siaka Toure;Bertin Kouadio;Catherine Seyler;Catherine Seyler;Moussa Traore

  • Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.

    Raoul Moh;Christine Danel;Eugène Messou;Timothée Ouassa

  • Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

    Anani Badje;Raoul Moh;Delphine Gabillard;Calixte Guéhi

  • When to Start Antiretroviral Therapy in Resource-limited Settings

    Rochelle P. Walensky;Lindsey L. Wolf;Robin Wood;Mariam O. Fofana

  • Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire.

    Armelle Pasquet;Eugène Messou;Delphine Gabillard;Albert Minga

  • Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.

    Raoul Moh;Christine Danel;Souleymane Sorho;Delphine Sauvageot

  • Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.

    Daouda Sissoko;Sophie Duraffour;Romy Kerber;Jacques Seraphin Kolie

  • Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.

    Catherine Seyler;Siaka Toure;Eugène Messou;Dominique Bonard

  • Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.

    Catherine Seyler;Xavier Anglaret;Nicole Dakoury-Dogbo;Eugène Messou

  • AIDS and Non-AIDS Morbidity and Mortality Across the Spectrum of CD4 Cell Counts in HIV-Infected Adults Before Starting Antiretroviral Therapy in Côte d’Ivoire

    Xavier Anglaret;Albert Minga;Delphine Gabillard;Timothée Ouassa

  • Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts.

    François Dabis;Eric Balestre;Paula Braitstein;Paolo Miotti

  • Dose regimen of favipiravir for Ebola virus disease

    Anne-Marie Taburet;Anne-Marie Taburet;Jeremie Guedj;Jeremie Guedj;Xavier Anglaret

  • Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis

    Rochelle P. Walensky;Robin Wood;Andrea L. Ciaranello;A. David Paltiel

  • Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to Child

    Daouda Sissoko;Mory Keïta;Boubacar Diallo;Negar Aliabadi

  • Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with Hiv/aids in Côte d’ivoire: a trial-based analysis

    Yazdanpanah Y;Losina E;Anglaret X;Goldie Sj

  • Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire.

    Xavier Anglaret;Eugène Messou;Timothée Ouassa;Siaka Toure

Frequent Co-Authors

François Dabis
François Dabis University of Bordeaux
Kenneth A. Freedberg
Kenneth A. Freedberg Harvard University
Elena Losina
Elena Losina Brigham and Women's Hospital
Rochelle P. Walensky
Rochelle P. Walensky Harvard University
Karine Lacombe
Karine Lacombe Hôpital Saint-Antoine
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Constance Delaugerre
Constance Delaugerre Université Paris Cité
Milton C. Weinstein
Milton C. Weinstein Harvard University
Christine Rouzioux
Christine Rouzioux Necker-Enfants Malades Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their immunology knowledge, several related online degrees offer valuable career opportunities. Many students explore Psychiatric Mental Health Nurse Practitioner roles, and identifying pmhnp programs online with best clinical placement can be crucial for gaining hands-on experience and securing employment.

Cost is often a significant consideration, so prospective students may seek out the cheapest pmhnp programs online to earn their degree without incurring heavy debt. Balancing affordability with program quality will enhance career prospects in this competitive field.

Career transitions are common in healthcare. For example, those currently working as Family Nurse Practitioners might want to specialize further, and resources explaining how to move from fnp to acute care np can provide guidance on advancing clinical skills and certifications.

Salary expectations are another key factor. Understanding how much does a dnp make in different states helps students and professionals make informed decisions about degree investment and job relocation.

Best Scientists Citing Xavier Anglaret

Trending Scientists

Recently Published Articles